Pfizer $PFE gained more than 4% today. 🟢

That's thanks to the results of a study showing the same, and potentially higher, efficacy of the new oral weight loss pills than competitor Novo Nordisk's popular Ozempic injection.

This is great news as it makes taking it easier and, for many, more affordable. 
However, the tablet will be further tested, but I think there is huge...
Read more

Novavax $NVAX -> which one of you was happy yesterday?

I won't write an article...
Read more

BioNTech $BNTX

BioNTech reported its results yesterday.

This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.

It is also known for the development and production of the COVID-19 vaccine with Pfizer.

Results for the first quarter of this year :

Revenues : EUR 1.28 billion, first...
Read more

Pfizer $PFE

Pfizer reported its quarterly results yesterday.

Sector : Pharmaceuticals.

Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.

Products : Viagra or the vaccine against COVID-19.

Results :

Revenues : $18.3 billion

Earnings per share : $1.23

After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.